Literature DB >> 21256866

Long-term behavioral assessment of function in an experimental model for ischemic stroke.

Angelo Encarnacion1, Nobutaka Horie, Hadar Keren-Gill, Tonya M Bliss, Gary K Steinberg, Mehrdad Shamloo.   

Abstract

Middle cerebral artery occlusion (MCAO) in rats is a well-studied experimental model for ischemic stroke leading to brain infarction and functional deficits. Many preclinical studies have focused on a small time window after the ischemic episode to evaluate functional outcome for screening therapeutic candidates. Short evaluation periods following injury have led to significant setbacks due to lack of information on the delayed effects of treatments, as well as short-lived and reversible neuroprotection, so called false-positive results. In this report, we evaluated long-term functional deficit for 90 days after MCAO in two rat strains with two durations of ischemic insult, in order to identify the best experimental paradigm to assess injury and subsequent recovery. Behavioral outcomes were measured pre-MCAO followed by weekly assessment post-stroke. Behavioral tests included the 18-point composite neurological score, 28-point neuroscore, rearing test, vibrissae-evoked forelimb placing test, foot fault test and the CatWalk. Brain lesions were assessed to correlate injury to behavior outcomes at the end of study. Our results indicate that infarction volume in Sprague-Dawley rats was dependent on occlusion duration. In contrast, the infarction volume in Wistar rats did not correlate with the duration of ischemic episode. Functional outcomes were not dependent on occlusion time in either strain; however, measurable deficits were detectable long-term in limb asymmetry, 18- and 28-point neuroscores, forelimb placing, paw swing speed, and gait coordination. In conclusion, these behavioral assays, in combination with an extended long-term assessment period, can be used for evaluating therapeutic candidates in preclinical models of ischemic stroke.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21256866      PMCID: PMC3539723          DOI: 10.1016/j.jneumeth.2011.01.010

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  30 in total

1.  Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice.

Authors:  Michelle L Starkey; Andrew W Barritt; Ping K Yip; Meirion Davies; Frank P T Hamers; Stephen B McMahon; Elizabeth J Bradbury
Journal:  Exp Neurol       Date:  2005-10       Impact factor: 5.330

Review 2.  Postinfarct cortical plasticity and behavioral recovery.

Authors:  Randolph J Nudo
Journal:  Stroke       Date:  2007-02       Impact factor: 7.914

3.  Quantitative measurement of neurological deficit after mild (30 min) transient middle cerebral artery occlusion in rats.

Authors:  Kouji Wakayama; Munehisa Shimamura; Masataka Sata; Naoyuki Sato; Koji Kawakami; Hirotsugu Fukuda; Takuji Tomimatsu; Toshio Ogihara; Ryuichi Morishita
Journal:  Brain Res       Date:  2006-12-14       Impact factor: 3.252

4.  Functional testing in a mouse stroke model induced by occlusion of the distal middle cerebral artery.

Authors:  Judith Lubjuhn; Alexandra Gastens; Gertrud von Wilpert; Panagiotis Bargiotas; Oliver Herrmann; Sasidhar Murikinati; Tamer Rabie; Hugo H Marti; Hugo Marti; Ivo Amende; Tom G Hampton; Markus Schwaninger
Journal:  J Neurosci Methods       Date:  2009-08-04       Impact factor: 2.390

5.  Temporary middle cerebral artery occlusion in the rat: consistent protocol for a model of stroke and reperfusion.

Authors:  B S Aspey; F L Taylor; M Terruli; M J Harrison
Journal:  Neuropathol Appl Neurobiol       Date:  2000-06       Impact factor: 8.090

6.  Testing forelimb placing "across the midline" reveals distinct, lesion-dependent patterns of recovery in rats.

Authors:  Martin T Woodlee; Aloysha M Asseo-García; Xiurong Zhao; Shi-Jie Liu; Theresa A Jones; Timothy Schallert
Journal:  Exp Neurol       Date:  2005-02       Impact factor: 5.330

Review 7.  Lesion evolution in cerebral ischemia.

Authors:  Tobias Back; Thomas Hemmen; Olaf G Schüler
Journal:  J Neurol       Date:  2004-04       Impact factor: 4.849

8.  Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation.

Authors:  J H Garcia; S Wagner; K F Liu; X J Hu
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

9.  Inhibition of vascular endothelial growth factor receptor (VEGFR) signaling by BSF476921 attenuates regional cerebral edema following traumatic brain injury in rats.

Authors:  Philipp M Lenzlinger; Kathryn E Saatman; Rachel C Hoover; Jessica A Cheney; Florence M Bareyre; Ramesh Raghupathi; Lee D Arnold; Tracy K McIntosh
Journal:  Restor Neurol Neurosci       Date:  2004       Impact factor: 2.406

10.  Correlation between behavioral status and cerebral glucose utilization in rats following freezing lesion.

Authors:  L M Colle; L J Holmes; H M Pappius
Journal:  Brain Res       Date:  1986-11-05       Impact factor: 3.252

View more
  54 in total

1.  Intra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke.

Authors:  Yuhtaka Fukuda; Nobutaka Horie; Katsuya Satoh; Susumu Yamaguchi; Youichi Morofuji; Takeshi Hiu; Tsuyoshi Izumo; Kentaro Hayashi; Noriyuki Nishida; Izumi Nagata
Journal:  Cell Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.046

2.  Progesterone in transient ischemic stroke: a dose-response study.

Authors:  Seema Yousuf; Fahim Atif; Iqbal Sayeed; Huiling Tang; Donald G Stein
Journal:  Psychopharmacology (Berl)       Date:  2014-04-22       Impact factor: 4.530

3.  Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke.

Authors:  Yi Wang; Ryo Yoshimura; Hiroaki Manabe; Catherine Schretter; Ryon Clarke; Yu Cai; Mark Fitzgerald; Kevin S Lee
Journal:  Brain Res       Date:  2014-08-14       Impact factor: 3.252

Review 4.  Neurobehavioral testing in subarachnoid hemorrhage: A review of methods and current findings in rodents.

Authors:  Nefize Turan; Brandon A Miller; Robert A Heider; Maheen Nadeem; Iqbal Sayeed; Donald G Stein; Gustavo Pradilla
Journal:  J Cereb Blood Flow Metab       Date:  2016-10-01       Impact factor: 6.200

5.  Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke.

Authors:  Susumu Yamaguchi; Nobutaka Horie; Katsuya Satoh; Takeshi Ishikawa; Tsuyoshi Mori; Hajime Maeda; Yuhtaka Fukuda; Shunsuke Ishizaka; Takeshi Hiu; Yoichi Morofuji; Tsuyoshi Izumo; Noriyuki Nishida; Takayuki Matsuo
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-15       Impact factor: 6.200

Review 6.  Optimizing functional outcome endpoints for stroke recovery studies.

Authors:  Mustafa Balkaya; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2019-09-14       Impact factor: 6.200

7.  Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation.

Authors:  Ahmet Arac; Sara E Brownell; Jonathan B Rothbard; Charlene Chen; Rose M Ko; Marta P Pereira; Gregory W Albers; Lawrence Steinman; Gary K Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-26       Impact factor: 11.205

8.  Variation in behavioral deficits and patterns of recovery after stroke among different rat strains.

Authors:  Allison Kunze; Dannielle Zierath; Olga Drogomiretskiy; Kyra Becker
Journal:  Transl Stroke Res       Date:  2014-04-08       Impact factor: 6.829

9.  A peptide mimetic of tyrosine phosphatase STEP as a potential therapeutic agent for treatment of cerebral ischemic stroke.

Authors:  Ranjana Poddar; Sathyanarayanan Rajagopal; Lucas Winter; Andrea M Allan; Surojit Paul
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-07       Impact factor: 6.200

10.  U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female rats.

Authors:  Hilda Ahnstedt; Maryam Mostajeran; Frank W Blixt; Karin Warfvinge; Saema Ansar; Diana N Krause; Lars Edvinsson
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.